•  
  •  
  •  
  •  

2026-04-21 09:41:27

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Biocon Receives Health Canada Approval of Bosaya™ and Vevzuo™, Biosimilars to Prolia® and Xgeva®
  • CleanMax to supply hybrid renewable power to Shell's LNG terminal and technology centre in India
  • Smartworks Becomes India's First Listed Flex Space Provider to Cross 10 Million Sq. Ft. Operational Portfolio
  • Mobavenue Recognized as AI-Powered Consumer Growth Platform and Technology-Led Marketing Campaigner at DIGIXX Awards 2026
  • Orbicular's Partner secures tentative U.S. ANDA approval for a generic version of Semaglutide Injection, supported by OneSource as CDMO partner

Keywords Selected:  IREDA

IPO News

  • Indian Renewable Energy Development Agency IPO subscribed 39 times on Final Day
  • Indian Renewable Energy Development Agency IPO subscribed 4.56 times on Day 2
  • Indian Renewable Energy Development Agency IPO fully subscribed on Day 1
  • Indian Renewable Energy Development Agency Ltd's IPO to open on Tuesday, November 21, 2023
  • Indian Renewable Energy Development Agency files DRHP for IPO

Stock Report

  • IREDA's IFSC Arm IGGEFIL Secures 'BBB+/Stable' International Rating
  • IREDA Declares Interim Dividend of ₹0.60 Per Share
  • IREDA Enhances Borrowing Limits to Rs 35,800 Cr for FY26
  • IREDA's Subsidiary IGGEFIL Sanctions Its First International Green Energy Loan
  • IREDA posts strong performance up to December 2025, with 44% Surge in Loan Disbursements
  • S&P Global Ratings Upgrades IREDA's Long-Term International Credit Rating to 'BBB' with Stable Outlook
  • Indian Renewable Energy Development Agency Ltd consolidated Q2FY26 PAT climbs to Rs. 549.33 crores
  • IREDA sanctions loan of Rs. 1134 crores to Insolation Green Energy Pvt Ltd
  • IREDA Raises ₹453 Crore Via Perpetual Bonds, Issue Oversubscribed 2.69 Times
  • IREDA signs Performance MoU with MNRE, ₹8,200 Crore, Revenue Target for FY 2025-26
  • IREDA Successfully Raises 2,005.90 Crore via QIP to Boost Green Financing
  • Indian Renewable Energy Development Agency Ltd Q4 FY2025 consolidated PAT increases to Rs. 501.55 crores
  • IREDA signs facility agreement for ECBs from SBI
  • IREDA Secures JPY 26 Billion ECB Facility from SBI Tokyo
  • IREDA raises ₹910.37 Crore through Privately Placed Tier-II Bonds
  • IREDA launches First-Ever Perpetual Bonds to raise ₹1,247 Crore, receives ₹24.48 Crore Tax Refund
  • IREDA Bags Triple Honours at 14th PSE Excellence Awards
  • CMD, IREDA Highlights Rajasthan's Renewable Energy Potential at Rising Rajasthan Summit
  • Indian Renewable Energy Development Agency Ltd Q2 FY2025 net profit at Rs. 387.74 crores
  • IREDA Global Green Energy Finance IFSC Limited received provisional registration from IFSCA
  • SJVN Ltd, GMR Upper Karnalai Hydro Power Ltd and IREDA sign MoU for 900 MW project in Nepal
  • IREDA and BHEL Discuss Joint Efforts to Accelerate India's Renewable Energy Growth
  • IREDA allocates Rs. 1.05 Crore for Development of Sport Science Centre in Uttarakhand
  • Indowind Energy Ltd clears term loan with IREDA

Latest Post

  • Biocon Receives Health Canada Approval of Bosaya™ and Vevzuo™, Biosimilars to Prolia® and Xgeva®
  • CleanMax to supply hybrid renewable power to Shell's LNG terminal and technology centre in India
  • Smartworks Becomes India's First Listed Flex Space Provider to Cross 10 Million Sq. Ft. Operational Portfolio
  • Mobavenue Recognized as AI-Powered Consumer Growth Platform and Technology-Led Marketing Campaigner at DIGIXX Awards 2026
  • Orbicular's Partner secures tentative U.S. ANDA approval for a generic version of Semaglutide Injection, supported by OneSource as CDMO partner


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025